Does DEXTROAMPHETAMINE Cause Product dose omission issue? 100 Reports in FDA Database
Sharpen Your Memory & Focus Naturally
NeuroZoom — 35 clinically studied ingredients. No stimulants. Pure brain support.
According to the FDA Adverse Event Reporting System (FAERS), 100 reports of Product dose omission issue have been filed in association with DEXTROAMPHETAMINE (Zenzedi). This represents 4.7% of all adverse event reports for DEXTROAMPHETAMINE.
100
Reports of Product dose omission issue with DEXTROAMPHETAMINE
4.7%
of all DEXTROAMPHETAMINE reports
0
Deaths
1
Hospitalizations
How Dangerous Is Product dose omission issue From DEXTROAMPHETAMINE?
Of the 100 reports, 1 (1.0%) required hospitalization.
Is Product dose omission issue Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for DEXTROAMPHETAMINE. However, 100 reports have been filed with the FAERS database.
What Other Side Effects Does DEXTROAMPHETAMINE Cause?
Drug ineffective (513)
Fatigue (170)
Anxiety (169)
Product substitution issue (163)
Headache (145)
Nausea (130)
Off label use (121)
Somnolence (110)
Feeling abnormal (108)
Product availability issue (106)
What Other Drugs Cause Product dose omission issue?
DUPILUMAB (18,189)
USTEKINUMAB (9,405)
GUSELKUMAB (9,267)
LENALIDOMIDE (8,145)
MEPOLIZUMAB (5,873)
TOFACITINIB (5,646)
VOXELOTOR (5,122)
BELIMUMAB (4,671)
SECUKINUMAB (4,572)
APREMILAST (4,460)
Which DEXTROAMPHETAMINE Alternatives Have Lower Product dose omission issue Risk?
DEXTROAMPHETAMINE vs DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE ASPARTATE, DEXTROAMPHETAMINE AND AMPHETAMINE
DEXTROAMPHETAMINE vs DEXTROMETHORPHAN
DEXTROAMPHETAMINE vs DEXTROMETHORPHAN HYDROBROMIDE
DEXTROAMPHETAMINE vs DEXTROMETHORPHAN HYDROBROMIDE\GUAIFENESIN
DEXTROAMPHETAMINE vs DEXTROMETHORPHAN HYDROBROMIDE\GUAIFENESIN\PHENYLEPHRINE